Encora Therapeutics Names Nadim Yared as Chairman and Chief Executive Officer

Encora Therapeutics, a clinical-stage medical technology company focused on neuromodulation treatments for movement disorders, has announced the immediate appointment of Nadim Yared as Chairman and Chief Executive Officer. Daniel Carballo, who co-founded the company and served as CEO, will continue with Encora as Vice President of Strategy. With Nadim’s leadership, the company plans to advance its late-stage clinical programs, enhance regulatory and reimbursement strategies, and grow its strategic partnerships to speed patient access to therapies.

Health Technology Insights: Low Access To COVID Pills Despite High Awareness: Global Healthy Living Foundation Report

Daniel Carballo, Co-Founder and incoming Vice President of Strategy, shared his enthusiasm about the transition. He said the motivation behind founding Encora was to help restore independence for individuals with movement disorders. Reflecting on the company’s achievements, he expressed pride in the work done by the team, investigators, and patients. He emphasized Nadim’s experience in scaling medtech firms and his ability to integrate product development with evidence-building and commercialization efforts. Carballo looks forward to collaborating closely with Nadim to bring Encora’s therapy to patients more quickly.

Health Technology Insights: Applied Policy Welcomes Cheryl Powell as Vice President of Health Policy

Nadim Yared, now Chairman and CEO, expressed his honor at joining Encora during such an important phase. He praised the team for developing a patient-focused platform that has the potential to significantly improve the daily lives of those affected by movement disorders. Nadim stated his commitment to generating solid clinical data, creating scalable commercial strategies, and working hand-in-hand with clinicians and patients to ensure meaningful results.

Health Technology Insights: Health Technology Insights: Latest News And Innovations – Roundup 26 September 2025

To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com